Navigation Links
Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
Date:12/5/2010

innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medial healthcare needs; and to identify promising product candidates based on exceptional scientific development expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate. We exist to make a difference for the better and these are important times to do just that.

Presently, Pharmacyclics has four product candidates in clinical development, a clinical development candidate in late stage pre clinical evaluation and several preclinical molecules in lead optimization. We are committed to high standards of ethics, scientific rigor, and operational efficiency as we move each of these programs to viable commercialization. The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.

NOTE: This announcement may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding our expectations and beliefs regarding our future results or performance. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "should", "would", "project", "plan", "predict", "intend" and similar expressions are intended to identify such forward-looking statements. Our ac
'/>"/>

SOURCE Pharmacyclics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
2. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
3. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
4. Pharmacyclics to Present at the RBC Capital Markets Healthcare Investor Conference
5. Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results
6. Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7
7. Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
8. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
10. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
11. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)...  Respiratory Motion, Inc. – Research being presented ... the Japanese Society of Anesthesiologists shows that commonly ... miss critical early indicators of impending deterioration and ... that respiratory volume monitoring using the ExSpiron™ Patient ... patients than traditional capnography and pulse oximetry technologies ...
(Date:5/26/2015)... May 26, 2015  MGC Diagnostics Corporation (NasdaqCM: MGCD), a ... discuss its financial results for the second quarter of fiscal ... 4:30 p.m. ET on Tuesday, June 2, 2015. The Company ... 2015 at the close of the markets on Tuesday, June ... or (412) 317-6789 to access the conference call, or listen ...
(Date:5/26/2015)... , May 26, 2015 Helping seniors ... as possible can be a full-time job for ... systems bridge the gap when they can,t be ... However, cautions eHeart Health Monitoring, LLC , ... ...
Breaking Medicine Technology:Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 2Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 3Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 5MGC Diagnostics Corporation to Report Second Quarter Fiscal 2015 Financial Results on Tuesday, June 2, 2015 2eHeart Health Monitoring Gives Tips on Choosing the Right Personal Alert System for Aging Loved Ones 2eHeart Health Monitoring Gives Tips on Choosing the Right Personal Alert System for Aging Loved Ones 3eHeart Health Monitoring Gives Tips on Choosing the Right Personal Alert System for Aging Loved Ones 4
... SAN DIEGO, May 20 A post hoc analysis ... 302) of Shire plc,s,(LSE: SHP, Nasdaq: SHPGY) ulcerative colitis ... Week (DDW). Study 302 (further,referred to as "Kamm study," ... in London, UK), demonstrated LIALDA was effective in inducing,remission ...
... CRANBURY, N.J., May 20 Palatin Technologies,Inc. (Amex: ... been initiated in a Phase,2a clinical study of ... in subjects with controlled hypertension., The study ... five cohorts receiving escalating doses. As many as ...
Cached Medicine Technology:Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 6Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 2Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 3
(Date:5/26/2015)... Octo Consulting Group (Octo), an award-winning ... to the federal marketplace, has named Gaurav “GP” Pal ... this newly created role, Pal will be responsible for ... computing, big data, and digital services. , “We’re excited ... we continue to bring clients new and innovative solutions ...
(Date:5/26/2015)... May 26, 2015 Relias Learning ... for the health and human services market, announces expansion ... demand. After strong attendance and participation in 2014, they ... give their annual user conference an exciting new facelift. ... to come together and discuss best practices, share their ...
(Date:5/26/2015)... Pasadena, CA (PRWEB) May 26, 2015 ... is now offering complimentary dental cleanings with cosmetic treatments. ... , Cosmetic Dentistry , “We are committed ... giving you cutting-edge technology, outstanding customer service and a ... not only to change your smiles but to change ...
(Date:5/26/2015)... National Prevention Week , National Prevention Week ... supported by the Substance Abuse and Mental Health Services ... and action about, substance abuse as well as mental ... encouraged to join in promoting prevention strategies, in educating ... in building community partnerships. , The Voice of One, ...
(Date:5/26/2015)... York, NY (PRWEB) May 26, 2015 Award-winning ... for a good cause. "The photography show will connect viewers ... in their lives.” For the last five years, Raul has ... to convey the notion that we are not bounded by ... a language spoken in Raul’s native country, Bolivia. The photo ...
Breaking Medicine News(10 mins):Health News:Octo Consulting Group (Octo) Appoints Gaurav “GP” Pal as Vice President of Technology Strategy and Cloud Solutions 2Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:Pasadena Porcelain Veneers Expert, Marine Martirosyan DDS, is Now Offering Complimentary Dental Cleaning with Cosmetic Treatments 2Health News:Narconon Arrowhead Takes Part in National Prevention Week 2Health News:Narconon Arrowhead Takes Part in National Prevention Week 3Health News:A Photographer & Two Educational Organiazations Join to Make a Difference in Our Youth 2
... Time" a Valuable Present: Peake, WASHINGTON, Dec. 21 ... volunteers who remember our nation,s,veterans, especially those hospitalized in ... "Some of our patients will be unable to ... B. Peake, Secretary of Veterans Affairs. "The,good cheer and ...
... research suggests , FRIDAY, Dec. 21 (HealthDay News) -- Treating ... concludes a University of Pennsylvania School of Medicine study in ... , It found that providing depression care management to older ... over five years by about 50 percent. , "Depression is ...
... for ambulatory care ... ... Cardiac Science,Corporation, (Nasdaq: CSCX ), a leading provider of ... of its HeartCentrix(R) ECG informatics software with Greenway,Medical Technology,s PrimeSuite(R) ...
... Milk Processors and, Bally Total Fitness to Shape Up ... ... SILVER SPRING, Md., Dec. 21 Discovery Health,s fifth,annual NATIONAL ... biggest and best year yet, with online registration beginning on,December ...
... costs of providing comprehensive screening and diagnostic services to ... or cervical cancer for treatment. Dr. Donatus U. Ekwueme ... Health Promotion at the Centers for Disease Control and ... cost of screening a woman for breast cancer was ...
... 20 ISTA Pharmaceuticals,Inc. (Nasdaq: ISTA ), ... Drug,Application (NDA) to the U.S. Food and Drug ... seeking approval for Xibrom QD,as a treatment for ... (bromfenac ophthalmic solution), Xibrom is a topical ...
Cached Medicine News:Health News:VA Salutes Volunteers' Spreading Holiday Cheer 2Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies 2Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies 3Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies 4Health News:Discovery Health's Fifth Annual National Body Challenge Takes a Stand Against Obesity by Offering the Keys to Adopting a Healthy, Active Lifestyle 2Health News:Discovery Health's Fifth Annual National Body Challenge Takes a Stand Against Obesity by Offering the Keys to Adopting a Healthy, Active Lifestyle 3Health News:Study determines costs of breast and cervical cancer detection among low-income women 2Health News:ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily) 2
... Ergonomic Design for Unparalleled Comfort Pick one ... the balance. Notice the trigger and ejector positionsright ... because our pipettors are ergonomically designed to help ... of pipetting. Productivity In The Palm Of ...
... Unparalleled Comfort Pick one of our pipettors ... the trigger and ejector positionsright where they should ... are ergonomically designed to help avoid repetitive stress ... Productivity In The Palm Of Your Hand ...
... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...
... The total ergonomic solution and best value ... feather touch action and ultra lightweight design ... tip ejection with long, lever tip ejector ... , Accepts universal tips or for greater ...
Medicine Products: